| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | CDHR1 ADGRV1 DYSF MYL7 BMP1 CABYR DST PCDH11X HSPA5 HSPG2 PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PCDHB18P MYOF MICU3 HMCN1 PCDHGB4 LRP1 MACF1 MICU2 CDH2 | 5.27e-06 | 749 | 243 | 25 | GO:0005509 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GPHN MYO1D MAP1B CENPE MAP4 SPTB GBP3 SYNPO KATNAL1 ADGRV1 NEB DYSF SPTBN5 PTPN4 CYFIP1 DST RAB39B TRIM36 SPATA4 SYNM STXBP5L KIF26B SYNE1 SLC26A5 PPARG PTPRT FMNL3 MACF1 ROCK1 SSH2 EPB41L1 | 1.15e-05 | 1099 | 243 | 31 | GO:0008092 |
| GeneOntologyMolecularFunction | RNA 7-methylguanosine cap binding | 1.95e-05 | 14 | 243 | 4 | GO:0000340 | |
| GeneOntologyMolecularFunction | RNA cap binding | 1.09e-04 | 21 | 243 | 4 | GO:0000339 | |
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 1.47e-04 | 2 | 243 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1D CENPE VWA8 ZGRF1 KATNAL1 CLPX IQCA1L ATAD2B HSPA5 ACSS3 LONP2 KIF26B DHX37 DNAH2 UPF1 MSH6 DNAH12 RUVBL1 MACF1 | 1.98e-04 | 614 | 243 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 2.10e-04 | 45 | 243 | 5 | GO:0043495 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | VWA8 GBP3 KATNAL1 CLPX EFTUD2 IQCA1L SEPTIN14 ATAD2B HRAS RAB39B HSPA5 KRAS NRAS LONP2 DHX37 DNAH2 UPF1 DNAH12 RUVBL1 MACF1 RAB15 DIRAS2 | 2.12e-04 | 775 | 243 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | VWA8 GBP3 KATNAL1 CLPX EFTUD2 IQCA1L SEPTIN14 ATAD2B HRAS RAB39B HSPA5 KRAS NRAS LONP2 DHX37 DNAH2 UPF1 NUDT6 DNAH12 RUVBL1 MACF1 RAB15 DIRAS2 | 2.51e-04 | 839 | 243 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | VWA8 GBP3 KATNAL1 CLPX EFTUD2 IQCA1L SEPTIN14 ATAD2B HRAS RAB39B HSPA5 KRAS NRAS LONP2 DHX37 DNAH2 UPF1 NUDT6 DNAH12 RUVBL1 MACF1 RAB15 DIRAS2 | 2.55e-04 | 840 | 243 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | VWA8 GBP3 KATNAL1 CLPX EFTUD2 IQCA1L SEPTIN14 ATAD2B HRAS RAB39B HSPA5 KRAS NRAS LONP2 DHX37 DNAH2 UPF1 NUDT6 DNAH12 RUVBL1 MACF1 RAB15 DIRAS2 | 2.55e-04 | 840 | 243 | 23 | GO:0016818 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDHR1 PCDH11X DSCAM PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PTPRT PCDHB18P HMCN1 PCDHGB4 CDH2 | 4.51e-08 | 187 | 241 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDHR1 MDGA2 PCDH11X DSCAM PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PTPRT PCDHB18P TENM4 HMCN1 PCDHGB4 CDH2 | 9.31e-07 | 313 | 241 | 16 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell junction organization | GPHN GABRG3 AGO2 MAP1B MYCBP2 SPTB MPDZ MDGA2 SYNPO POTEKP BMP6 CYFIP1 DST RAB39B WHRN DSCAM KALRN FRMPD2 PCDHB2 PTPRT CYFIP2 TENM4 TJP1 LRP1 MACF1 ROCK1 CDH2 | 2.96e-05 | 974 | 241 | 27 | GO:0034330 |
| HumanPheno | Linear nevus sebaceous | 5.70e-06 | 3 | 92 | 3 | HP:0010817 | |
| Domain | Spectrin_repeat | 5.97e-08 | 29 | 237 | 7 | IPR002017 | |
| Domain | SPEC | 1.25e-07 | 32 | 237 | 7 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.25e-07 | 32 | 237 | 7 | IPR018159 | |
| Domain | CA | CDHR1 FREM2 PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PCDHGB4 CDH2 | 2.43e-07 | 115 | 237 | 11 | SM00112 |
| Domain | Cadherin | CDHR1 FREM2 PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PCDHGB4 CDH2 | 3.16e-07 | 118 | 237 | 11 | IPR002126 |
| Domain | Spectrin | 3.30e-07 | 23 | 237 | 6 | PF00435 | |
| Domain | P-loop_NTPase | MYO1D NLRP7 CENPE VWA8 ZGRF1 GBP3 KATNAL1 CLPX EFTUD2 SEPTIN14 ATAD2B HRAS UCK2 AK1 CHST2 RAB39B KRAS NRAS LONP2 KIF26B DHX37 DNAH2 UPF1 PAPSS1 MSH6 DNAH12 RUVBL1 TJP1 RAB15 DIRAS2 | 3.86e-07 | 848 | 237 | 30 | IPR027417 |
| Domain | - | NLRP7 VWA8 ZGRF1 GBP3 KATNAL1 CLPX EFTUD2 SEPTIN14 ATAD2B HRAS UCK2 AK1 CHST2 RAB39B KRAS NRAS LONP2 DHX37 DNAH2 UPF1 PAPSS1 MSH6 DNAH12 RUVBL1 TJP1 RAB15 DIRAS2 | 1.00e-06 | 746 | 237 | 27 | 3.40.50.300 |
| Domain | Cadherin_CS | CDHR1 PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PCDHGB4 CDH2 | 1.27e-06 | 109 | 237 | 10 | IPR020894 |
| Domain | CADHERIN_1 | CDHR1 PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PCDHGB4 CDH2 | 1.77e-06 | 113 | 237 | 10 | PS00232 |
| Domain | Cadherin | CDHR1 PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PCDHGB4 CDH2 | 1.77e-06 | 113 | 237 | 10 | PF00028 |
| Domain | - | CDHR1 PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PCDHGB4 CDH2 | 1.92e-06 | 114 | 237 | 10 | 2.60.40.60 |
| Domain | CADHERIN_2 | CDHR1 PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PCDHGB4 CDH2 | 1.92e-06 | 114 | 237 | 10 | PS50268 |
| Domain | Cadherin-like | CDHR1 PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 FAT3 PCDHB2 PCDHA7 PCDHGB4 CDH2 | 2.25e-06 | 116 | 237 | 10 | IPR015919 |
| Domain | ACTININ_2 | 8.81e-06 | 23 | 237 | 5 | PS00020 | |
| Domain | ACTININ_1 | 8.81e-06 | 23 | 237 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.81e-06 | 23 | 237 | 5 | IPR001589 | |
| Domain | Cadherin_C | 1.40e-05 | 42 | 237 | 6 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.40e-05 | 42 | 237 | 6 | PF16492 | |
| Domain | Cadherin_2 | 1.81e-05 | 65 | 237 | 7 | PF08266 | |
| Domain | Cadherin_N | 1.81e-05 | 65 | 237 | 7 | IPR013164 | |
| Domain | Ferlin_B-domain | 1.98e-05 | 5 | 237 | 3 | IPR012561 | |
| Domain | Ferlin_C | 1.98e-05 | 5 | 237 | 3 | PF16165 | |
| Domain | FerIin_dom | 1.98e-05 | 5 | 237 | 3 | IPR012968 | |
| Domain | FerI | 1.98e-05 | 5 | 237 | 3 | PF08151 | |
| Domain | FerB | 1.98e-05 | 5 | 237 | 3 | PF08150 | |
| Domain | FerI | 1.98e-05 | 5 | 237 | 3 | SM01202 | |
| Domain | FerB | 1.98e-05 | 5 | 237 | 3 | SM01201 | |
| Domain | Ferlin_C | 1.98e-05 | 5 | 237 | 3 | IPR032362 | |
| Domain | HnRNP_R/Q_splicing_fac | 1.98e-05 | 5 | 237 | 3 | IPR006535 | |
| Domain | - | 3.92e-05 | 6 | 237 | 3 | 3.90.1290.10 | |
| Domain | Plectin | 6.80e-05 | 7 | 237 | 3 | PF00681 | |
| Domain | Plectin_repeat | 6.80e-05 | 7 | 237 | 3 | IPR001101 | |
| Domain | PLEC | 6.80e-05 | 7 | 237 | 3 | SM00250 | |
| Domain | VWA | 7.49e-05 | 56 | 237 | 6 | PF00092 | |
| Domain | VWFA | 8.21e-05 | 82 | 237 | 7 | PS50234 | |
| Domain | VWA | 9.58e-05 | 84 | 237 | 7 | SM00327 | |
| Domain | Cadherin_tail | 9.87e-05 | 37 | 237 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 9.87e-05 | 37 | 237 | 5 | IPR031904 | |
| Domain | Cytoplasmic_FMR1-int | 1.60e-04 | 2 | 237 | 2 | IPR008081 | |
| Domain | FragX_IP | 1.60e-04 | 2 | 237 | 2 | PF05994 | |
| Domain | Exosome_RNA_bind1/RRP40/RRP4 | 1.60e-04 | 2 | 237 | 2 | IPR026699 | |
| Domain | KH_6 | 1.60e-04 | 2 | 237 | 2 | PF15985 | |
| Domain | VWF_A | 2.68e-04 | 99 | 237 | 7 | IPR002035 | |
| Domain | E3_binding | 4.77e-04 | 3 | 237 | 2 | PF02817 | |
| Domain | Ferlin_A-domain | 4.77e-04 | 3 | 237 | 2 | IPR012560 | |
| Domain | FerA | 4.77e-04 | 3 | 237 | 2 | PF08165 | |
| Domain | E3-bd | 4.77e-04 | 3 | 237 | 2 | IPR004167 | |
| Domain | Carb-bd_sugar_hydrolysis-dom | 4.77e-04 | 3 | 237 | 2 | IPR006633 | |
| Domain | FerA | 4.77e-04 | 3 | 237 | 2 | SM01200 | |
| Domain | CASH | 4.77e-04 | 3 | 237 | 2 | SM00722 | |
| Domain | - | 4.77e-04 | 3 | 237 | 2 | 4.10.320.10 | |
| Domain | AAA+_ATPase | 5.11e-04 | 144 | 237 | 8 | IPR003593 | |
| Domain | AAA | 5.11e-04 | 144 | 237 | 8 | SM00382 | |
| Domain | EGF-like_CS | EPHB4 PTGS2 BMP1 PLAT HSPG2 FAT3 ADAM30 AREG TENM4 HMCN1 LRP1 | 5.25e-04 | 261 | 237 | 11 | IPR013032 |
| Domain | EGF_2 | EPHB4 PTGS2 BMP1 PLAT HSPG2 FAT3 ADAM30 AREG TENM4 HMCN1 LRP1 | 5.96e-04 | 265 | 237 | 11 | PS01186 |
| Domain | ATPase_AAA_core | 6.01e-04 | 54 | 237 | 5 | IPR003959 | |
| Domain | ATPase_dyneun-rel_AAA | 6.62e-04 | 14 | 237 | 3 | IPR011704 | |
| Domain | AAA_5 | 6.62e-04 | 14 | 237 | 3 | PF07728 | |
| Domain | EGF_3 | 8.70e-04 | 235 | 237 | 10 | PS50026 | |
| Domain | CAT-like_dom | 9.46e-04 | 4 | 237 | 2 | IPR023213 | |
| Domain | 2-oxoacid_dh | 9.46e-04 | 4 | 237 | 2 | PF00198 | |
| Domain | DUF1394 | 9.46e-04 | 4 | 237 | 2 | IPR009828 | |
| Domain | 2-oxoacid_DH_actylTfrase | 9.46e-04 | 4 | 237 | 2 | IPR001078 | |
| Domain | Peroxin/Ferlin | 9.46e-04 | 4 | 237 | 2 | IPR006614 | |
| Domain | DUF1394 | 9.46e-04 | 4 | 237 | 2 | PF07159 | |
| Domain | DysFC | 9.46e-04 | 4 | 237 | 2 | SM00694 | |
| Domain | DysFN | 9.46e-04 | 4 | 237 | 2 | SM00693 | |
| Domain | - | 9.46e-04 | 4 | 237 | 2 | 3.30.559.10 | |
| Domain | RAS | 9.72e-04 | 35 | 237 | 4 | PS51421 | |
| Domain | cNMP-bd_CS | 1.00e-03 | 16 | 237 | 3 | IPR018488 | |
| Domain | FN3 | 1.02e-03 | 199 | 237 | 9 | PS50853 | |
| Domain | EGF | 1.14e-03 | 126 | 237 | 7 | PF00008 | |
| Domain | Small_GTPase_Ras | 1.20e-03 | 37 | 237 | 4 | IPR020849 | |
| Domain | EGF-like_dom | 1.35e-03 | 249 | 237 | 10 | IPR000742 | |
| Domain | CH | 1.40e-03 | 65 | 237 | 5 | SM00033 | |
| Domain | FN3_dom | 1.44e-03 | 209 | 237 | 9 | IPR003961 | |
| Domain | PHR | 1.56e-03 | 5 | 237 | 2 | IPR012983 | |
| Domain | LIPOYL | 1.56e-03 | 5 | 237 | 2 | PS00189 | |
| Domain | 2-oxoA_DH_lipoyl-BS | 1.56e-03 | 5 | 237 | 2 | IPR003016 | |
| Domain | Autophagy-rel_C | 1.56e-03 | 5 | 237 | 2 | IPR015412 | |
| Domain | PHR | 1.56e-03 | 5 | 237 | 2 | PF08005 | |
| Domain | ATG_C | 1.56e-03 | 5 | 237 | 2 | PF09333 | |
| Domain | EGF_1 | 1.61e-03 | 255 | 237 | 10 | PS00022 | |
| Domain | CH | 1.95e-03 | 70 | 237 | 5 | PF00307 | |
| Domain | - | 2.08e-03 | 71 | 237 | 5 | 1.10.418.10 | |
| Domain | Rossmann-like_a/b/a_fold | 2.12e-03 | 43 | 237 | 4 | IPR014729 | |
| Domain | - | 2.12e-03 | 43 | 237 | 4 | 3.40.50.620 | |
| Domain | GAR | 2.33e-03 | 6 | 237 | 2 | PS51460 | |
| Domain | Acid_Pase_AS | 2.33e-03 | 6 | 237 | 2 | IPR033379 | |
| Domain | PbH1 | 2.33e-03 | 6 | 237 | 2 | IPR006626 | |
| Domain | GAS_dom | 2.33e-03 | 6 | 237 | 2 | IPR003108 | |
| Domain | Pectin_lyas_fold | 2.33e-03 | 6 | 237 | 2 | IPR012334 | |
| Domain | PbH1 | 2.33e-03 | 6 | 237 | 2 | SM00710 | |
| Domain | ITI_HC_C | 2.33e-03 | 6 | 237 | 2 | IPR010600 | |
| Domain | - | 2.33e-03 | 6 | 237 | 2 | 2.160.20.10 | |
| Domain | RIIa | 2.33e-03 | 6 | 237 | 2 | SM00394 | |
| Domain | GAS2 | 2.33e-03 | 6 | 237 | 2 | PF02187 | |
| Domain | - | 2.33e-03 | 6 | 237 | 2 | 3.30.920.20 | |
| Domain | ITI_HC_C | 2.33e-03 | 6 | 237 | 2 | PF06668 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 7.44e-06 | 40 | 169 | 6 | M62 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 1.66e-05 | 5 | 169 | 3 | M26921 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 1.82e-05 | 14 | 169 | 4 | M719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.45e-05 | 15 | 169 | 4 | M47497 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 3.30e-05 | 6 | 169 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 3.30e-05 | 6 | 169 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 3.30e-05 | 6 | 169 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 3.30e-05 | 6 | 169 | 3 | M47932 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 5.72e-05 | 7 | 169 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 5.72e-05 | 7 | 169 | 3 | M19489 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 6.71e-05 | 19 | 169 | 4 | M27423 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 8.50e-05 | 38 | 169 | 5 | MM14969 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 9.07e-05 | 8 | 169 | 3 | M27919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 9.07e-05 | 8 | 169 | 3 | M47935 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.05e-04 | 63 | 169 | 6 | M11187 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.23e-04 | 41 | 169 | 5 | MM15200 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 1.35e-04 | 9 | 169 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 1.35e-04 | 9 | 169 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 1.35e-04 | 9 | 169 | 3 | M27904 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 2.07e-04 | 25 | 169 | 4 | M39794 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | 2.07e-04 | 25 | 169 | 4 | M563 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 2.60e-04 | 11 | 169 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.60e-04 | 11 | 169 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.60e-04 | 11 | 169 | 3 | M47371 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 2.60e-04 | 11 | 169 | 3 | M27911 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 2.60e-04 | 11 | 169 | 3 | M27740 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 2.60e-04 | 11 | 169 | 3 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 2.60e-04 | 11 | 169 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 2.60e-04 | 11 | 169 | 3 | M47432 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.83e-04 | 106 | 169 | 7 | M27077 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.91e-04 | 49 | 169 | 5 | MM14837 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 3.26e-04 | 28 | 169 | 4 | M39572 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.44e-04 | 12 | 169 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 3.44e-04 | 12 | 169 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 3.44e-04 | 12 | 169 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 3.44e-04 | 12 | 169 | 3 | M39408 | |
| Pathway | KEGG_THYROID_CANCER | 3.75e-04 | 29 | 169 | 4 | M523 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 4.43e-04 | 13 | 169 | 3 | MM14701 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 4.43e-04 | 13 | 169 | 3 | M47594 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 4.43e-04 | 13 | 169 | 3 | M1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 5.59e-04 | 14 | 169 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 5.59e-04 | 14 | 169 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 5.59e-04 | 14 | 169 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 5.59e-04 | 14 | 169 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 5.59e-04 | 14 | 169 | 3 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 5.59e-04 | 14 | 169 | 3 | M569 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 5.59e-04 | 14 | 169 | 3 | M27908 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 5.59e-04 | 14 | 169 | 3 | M27734 | |
| Pathway | PID_TCR_RAS_PATHWAY | 5.59e-04 | 14 | 169 | 3 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 5.59e-04 | 14 | 169 | 3 | M47488 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 6.31e-04 | 121 | 169 | 7 | M39823 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 6.40e-04 | 58 | 169 | 5 | MM14736 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.40e-04 | 58 | 169 | 5 | M2049 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 6.93e-04 | 15 | 169 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 6.93e-04 | 15 | 169 | 3 | M47531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.45e-04 | 16 | 169 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 8.45e-04 | 16 | 169 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 8.45e-04 | 16 | 169 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 8.45e-04 | 16 | 169 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 8.45e-04 | 16 | 169 | 3 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 8.45e-04 | 16 | 169 | 3 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 8.45e-04 | 16 | 169 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 8.45e-04 | 16 | 169 | 3 | M47682 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 8.45e-04 | 16 | 169 | 3 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 8.45e-04 | 16 | 169 | 3 | M47483 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 8.71e-04 | 36 | 169 | 4 | M271 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 9.67e-04 | 37 | 169 | 4 | MM15022 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.02e-03 | 17 | 169 | 3 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 1.02e-03 | 17 | 169 | 3 | M47684 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 1.02e-03 | 17 | 169 | 3 | M27918 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.06e-03 | 132 | 169 | 7 | M11355 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 1.08e-03 | 213 | 169 | 9 | M18306 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 1.08e-03 | 65 | 169 | 5 | M38994 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 1.18e-03 | 39 | 169 | 4 | M39905 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 1.21e-03 | 18 | 169 | 3 | M27518 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 1.21e-03 | 18 | 169 | 3 | M39737 | |
| Pathway | REACTOME_TIE2_SIGNALING | 1.21e-03 | 18 | 169 | 3 | M11932 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.21e-03 | 18 | 169 | 3 | M657 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.30e-03 | 40 | 169 | 4 | MM14945 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 1.42e-03 | 19 | 169 | 3 | M47793 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 1.42e-03 | 19 | 169 | 3 | M559 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 1.42e-03 | 19 | 169 | 3 | M41732 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 1.56e-03 | 42 | 169 | 4 | M39703 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 1.56e-03 | 42 | 169 | 4 | MM15822 | |
| Pubmed | GPHN AGO2 MYCBP2 CENPE MPDZ SYNPO HCN2 DDB1 EFTUD2 CYFIP1 DST HRAS KRAS RGPD2 RANBP2 DSCAM KALRN SYNE1 UPF1 CYFIP2 TJP1 SUPT16H LRP1 PRKAR1B MACF1 ROCK1 SSH2 CDH2 EPB41L1 | 8.71e-11 | 963 | 249 | 29 | 28671696 | |
| Pubmed | GPHN AHCYL1 MLEC ACADM MAP1B MYCBP2 MAP4 VWA8 RPN1 ETFA SYNPO DBT TMCC2 DLAT AK1 CKAP4 MAP3K7 RGPD2 RANBP2 KALRN STXBP5L ATG2B YARS1 MICU3 TENM4 RUVBL1 TJP1 PRKAR1B MACF1 DIRAS2 EPB41L1 | 2.24e-10 | 1139 | 249 | 31 | 36417873 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO1D MAP4 RPN1 UGGT1 EVPL SYNPO DBT F5 DDB1 DPM1 ITIH2 NUP54 EFTUD2 CYFIP1 DST CKAP4 HSPA5 NUP160 SYNM DHX37 EXOSC3 UPF1 EXOSC2 YARS1 MSH6 MYOF RUVBL1 TJP1 SUPT16H PDCD11 RAB15 MICU2 | 5.88e-10 | 1257 | 249 | 32 | 36526897 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MLEC MYO1D MAP4 RPN1 VPS13C UGGT1 ETFA CLPX DBT DDB1 DPM1 EFTUD2 CYFIP1 DLAT CKAP4 CHST2 HSPA5 NUP160 RANBP2 HTRA2 DHX37 SYNE1 GEMIN5 UPF1 TARS2 YARS1 CYFIP2 POLR3A MSH6 THADA RUVBL1 SUPT16H PUS1 PDCD11 | 8.62e-10 | 1425 | 249 | 34 | 30948266 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CCPG1 AGO2 MLEC MYCBP2 RPN1 UGGT1 ETFA GBP3 DDB1 EFTUD2 DST TDRD10 HSPA5 KRAS NRAS SYNE1 DPP3 UPF1 CYFIP2 MSH6 MYOF RUVBL1 MACF1 RBM46 | 5.15e-09 | 807 | 249 | 24 | 30575818 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | AGO2 MLEC ACADM MYCBP2 RPN1 UGGT1 ETFA CLPX DDB1 DPM1 EFTUD2 CYFIP1 HRAS UCK2 HSPA5 NUP160 KRAS RGPD2 RANBP2 ZBTB33 NRAS HTRA2 DHX37 UPF1 TARS2 EXOSC2 POLR3A MSH6 NDUFAF4 RUVBL1 | 9.23e-09 | 1257 | 249 | 30 | 37317656 |
| Pubmed | AHCYL1 MLEC MAP1B MAP4 RPN1 MPDZ DDB1 DPM1 CYFIP1 DST CKAP4 HSPA5 RANBP2 ZBTB33 ATG2B UPF1 DENND4C MB21D2 RUVBL1 MACF1 ROCK1 EPB41L1 | 1.06e-08 | 708 | 249 | 22 | 39231216 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ACADM MYO1D MYCBP2 CENPE VWA8 RPN1 VPS13C ETFA CLPX DBT DDB1 SPTBN5 DST DLAT CKAP4 MAP3K7 NUP160 HTRA2 SYNM SYNE1 ATG2B RANBP6 UPF1 TARS2 YARS1 POLR3A THADA NDUFAF4 SUPT16H PUS1 PDCD11 DDRGK1 MICU2 | 1.06e-08 | 1496 | 249 | 33 | 32877691 |
| Pubmed | SMG1 AHCYL1 MYO1D NLRP7 MAP1B RPN1 UGGT1 SYNPO CLPX NEB FER1L6 NUP54 DST DLAT AK1 RAB39B PPIP5K2 HSPA5 RGPD2 RANBP2 PCDHGB2 PCDHGA11 PCDHGA10 SYNE1 DNAH2 CYFIP2 TJP1 DGKK SUPT16H PCDHGB4 DDRGK1 MACF1 | 1.58e-08 | 1442 | 249 | 32 | 35575683 | |
| Pubmed | GPHN SETD1A AGO2 MAP1B MYCBP2 MAP4 RPN1 MPDZ CYFIP1 HSPA5 ZBTB33 ATG2B GEMIN5 UPF1 MSH6 RUVBL1 TJP1 TET1 PDCD11 | 2.06e-08 | 549 | 249 | 19 | 38280479 | |
| Pubmed | SMG1 AHCYL1 ACADM MAP1B MPDZ CLPX DPM1 FREM2 DST METTL16 PPIP5K2 RBM47 ZNF574 LONP2 DHX37 RALGAPB TARS2 POLR3A MICU2 EPB41L1 | 5.96e-08 | 650 | 249 | 20 | 38777146 | |
| Pubmed | AGO2 MYO1D MAP4 RPN1 DDB1 EFTUD2 CYFIP1 CKAP4 RBM47 HSPA5 A1CF DHX37 GEMIN5 TRIM71 UPF1 EXOSC2 RUVBL1 | 6.04e-08 | 469 | 249 | 17 | 37314180 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 PCDHB2 PCDHA7 PCDHB18P PCDHGB4 | 6.19e-08 | 74 | 249 | 8 | 10817752 |
| Pubmed | AGO2 MAP4 ETFA DBT SEPTIN14 DLAT PDIA5 RBM47 HSPA5 BRWD1 A1CF NRAS DNAH2 SUPT16H | 8.38e-08 | 317 | 249 | 14 | 30997501 | |
| Pubmed | PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 PCDHB2 PCDHA7 PCDHB18P PCDHGB4 | 8.48e-08 | 77 | 249 | 8 | 10835267 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | SETD1A AHCYL1 URI1 MLEC CYP11A1 DPM1 MYSM1 SMYD2 RTF1 CYFIP1 SYNJ2 HPF1 RBM47 FNIP2 WHRN ARRDC5 RALGAPB RALGPS2 ARHGAP17 GRM8 DENND4C CYFIP2 RUFY2 TET1 RAB15 C2orf80 KDM7A ZRANB1 | 9.76e-08 | 1242 | 249 | 28 | 30973865 |
| Pubmed | EPHB4 AHCYL1 CCPG1 MLEC MYCBP2 VWA8 RPN1 UGGT1 ETFA MPDZ CLPX DBT DDB1 EFTUD2 DLAT PDIA5 CKAP4 HSPA5 SYNM SYNE1 RALGAPB UPF1 TARS2 THADA NDUFAF4 SUPT16H PRKAR1B PDCD11 DDRGK1 MACF1 EPB41L1 | 1.09e-07 | 1487 | 249 | 31 | 33957083 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDH11X PCDHGB2 PCDHGA11 PCDHGA10 PCDHB2 PCDHA7 PCDHB18P PCDHGB4 | 1.15e-07 | 80 | 249 | 8 | 10716726 |
| Pubmed | CENPE ZGRF1 NEB FER1L6 EFTUD2 DST HTRA2 SYNE1 FAT3 SUPT16H MACF1 PPIP5K1 | 1.45e-07 | 234 | 249 | 12 | 36243803 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAP1B MYCBP2 CENPE MAP4 RPN1 DBT DDB1 DPM1 DLAT CKAP4 DHX37 EXOSC3 UPF1 EXOSC2 MSH6 MB21D2 RUVBL1 SUPT16H PDCD11 MACF1 ZRANB1 | 1.63e-07 | 759 | 249 | 21 | 35915203 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.73e-07 | 57 | 249 | 7 | 32633719 | |
| Pubmed | URI1 AGO2 MYO1D MYCBP2 UGGT1 EYA1 CLPX DBT PTPN4 CKAP4 TRIM36 MAP3K7 HSPA5 RANBP2 RALGAPB TARS2 PTPRT CYFIP2 MSH6 TJP1 SUPT16H PUS1 ROCK1 SSH2 EPB41L1 | 1.78e-07 | 1049 | 249 | 25 | 27880917 | |
| Pubmed | RPN1 ETFA DDB1 DPM1 EFTUD2 HSPA5 NUP160 RANBP2 UPF1 RUVBL1 PDCD11 | 2.06e-07 | 197 | 249 | 11 | 31620119 | |
| Pubmed | 2.20e-07 | 59 | 249 | 7 | 32382008 | ||
| Pubmed | CCPG1 MAP1B DDB1 CKAP4 HSPA5 NUP160 RANBP2 ZBTB33 SYNM DHX37 RUVBL1 CENPI | 2.95e-07 | 250 | 249 | 12 | 33536335 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MAP1B MYCBP2 VWA8 RPN1 DBT DDB1 EFTUD2 DST PDIA5 CKAP4 PPIP5K2 HSPA5 RANBP2 KALRN DHX37 SYNE1 ARRDC5 TRIM71 UPF1 EXOSC2 MSH6 RUVBL1 TJP1 SUPT16H MACF1 | 3.16e-07 | 1082 | 249 | 25 | 38697112 |
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 3.63e-07 | 3 | 249 | 3 | 28116986 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 3.63e-07 | 3 | 249 | 3 | 19101897 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 33620658 | ||
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 3.63e-07 | 3 | 249 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 3.63e-07 | 3 | 249 | 3 | 7776260 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 25788415 | ||
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 3.63e-07 | 3 | 249 | 3 | 26799184 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 3.63e-07 | 3 | 249 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 3.63e-07 | 3 | 249 | 3 | 23240926 | |
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 3.63e-07 | 3 | 249 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 3.63e-07 | 3 | 249 | 3 | 17712732 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 24222113 | ||
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 3.63e-07 | 3 | 249 | 3 | 22945650 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 19303097 | ||
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 3.63e-07 | 3 | 249 | 3 | 20150643 | |
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 3.63e-07 | 3 | 249 | 3 | 9334313 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 3.63e-07 | 3 | 249 | 3 | 37013448 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 25977330 | ||
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 3.63e-07 | 3 | 249 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 3.63e-07 | 3 | 249 | 3 | 26253102 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 16573741 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 3.63e-07 | 3 | 249 | 3 | 20090846 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 21737741 | ||
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 17943694 | ||
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 3.63e-07 | 3 | 249 | 3 | 16761621 | |
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 20971740 | ||
| Pubmed | 3.63e-07 | 3 | 249 | 3 | 27119512 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FNBP1 URI1 AGO2 MAP1B MYCBP2 MAP4 VPS13C SPTB SYNPO KATNAL1 ADGRV1 PTPN4 SYNJ2 PDIA5 STXBP5L CCDC32 FRMPD2 RALGAPB EXOSC3 TARS2 NAALADL2 SH2B1 THADA PLXDC2 TJP1 LRP1 PRKAR1B MACF1 ZRANB1 EPB41L1 | 3.66e-07 | 1489 | 249 | 30 | 28611215 |
| Pubmed | AHCYL1 AGO2 MYO1D MAP4 RPN1 ETFA DBT DDB1 DPM1 EFTUD2 CYFIP1 HRAS DLAT OXSM MAP3K7 HSPA5 KRAS RANBP2 UPF1 SIM2 PAPSS1 EXOSC2 CYFIP2 MYOF RUVBL1 TJP1 WDR87 | 3.71e-07 | 1247 | 249 | 27 | 27684187 | |
| Pubmed | AHCYL1 URI1 MYO1D MAP1B RPN1 UGGT1 MPDZ POTEKP DBT DDB1 DPM1 EFTUD2 DLAT CKAP4 HSPA5 NUP160 RANBP2 HTRA2 EXOSC3 RANBP6 UPF1 TARS2 EXOSC2 POLR3A MSH6 RUVBL1 WDR87 SUPT16H | 4.19e-07 | 1335 | 249 | 28 | 29229926 | |
| Pubmed | GPHN AHCYL1 AGO2 MYO1D MAP1B MAP4 RPN1 SPTB SYNPO DDB1 PTGS2 CYFIP1 DST DLAT HSPA5 KALRN SYNE1 RBP3 GEMIN5 UPF1 YARS1 CYFIP2 TENM4 TJP1 MACF1 SSH2 CDH2 DIRAS2 EPB41L1 | 5.17e-07 | 1431 | 249 | 29 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A AHCYL1 AGO2 MAP1B MYCBP2 MAP4 RPN1 CLPX DDB1 DPM1 EFTUD2 CYFIP1 DST DLAT CKAP4 HSPA5 NUP160 RANBP2 DHX37 EXOSC3 GEMIN5 UPF1 POLR3A MSH6 RUVBL1 SUPT16H PDCD11 MACF1 | 5.47e-07 | 1353 | 249 | 28 | 29467282 |
| Pubmed | SMG1 MLEC ACADM MAP1B VWA8 RPN1 UGGT1 ETFA SYNPO CLPX DDB1 DPM1 EFTUD2 DST CKAP4 KRAS RANBP2 EXOSC3 RANBP6 GEMIN5 UPF1 EXOSC2 POLR3A MSH6 MYOF THADA NDUFAF4 SUPT16H PDCD11 | 5.87e-07 | 1440 | 249 | 29 | 30833792 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 5.92e-07 | 68 | 249 | 7 | 11230163 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | MYCBP2 MAP4 RPN1 DDB1 EFTUD2 CKAP4 HSPA5 RANBP2 GEMIN5 RUVBL1 | 6.01e-07 | 175 | 249 | 10 | 25756610 |
| Pubmed | SMG1 MYCBP2 ADGRV1 RTF1 DST TMCC2 SYNE1 RALGAPB MYOF TENM4 MACF1 | 7.73e-07 | 225 | 249 | 11 | 12168954 | |
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 8.54e-07 | 25 | 249 | 5 | 8493579 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 8.78e-07 | 72 | 249 | 7 | 10380929 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | GPHN AHCYL1 ACADM MAP1B MYCBP2 VWA8 RPN1 MPDZ CLPX DBT EFTUD2 CKAP4 NUP160 ZBTB33 LONP2 DPP3 BTBD2 POLR3A TJP1 BLOC1S5 SUPT16H LRP1 ZRANB1 | 1.13e-06 | 1005 | 249 | 23 | 19615732 |
| Pubmed | 1.21e-06 | 12 | 249 | 4 | 31732746 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | EPHB4 FNBP1 SMG1 AHCYL1 VPS13C CLPX SYNJ2 PDIA5 NUP160 SYNE1 UPF1 EXOSC2 DENND4C THADA CENPI MACF1 ROCK1 CDH2 EPB41L1 | 1.27e-06 | 719 | 249 | 19 | 35337019 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | URI1 MAP4 VWA8 RPN1 UGGT1 CLPX DDB1 DPM1 EFTUD2 RTF1 CYFIP1 DLAT UCK2 CKAP4 HSPA5 RANBP2 LONP2 EXOSC3 GEMIN5 UPF1 EXOSC2 YARS1 MSH6 RUVBL1 TJP1 SUPT16H DDRGK1 MACF1 | 1.31e-06 | 1415 | 249 | 28 | 28515276 |
| Pubmed | MYO1D MAP1B MYCBP2 MAP4 UGGT1 DDB1 DST ATAD2B DLAT NUP160 RANBP2 DHX37 GEMIN5 UPF1 MSH6 TJP1 PDCD11 MACF1 | 1.35e-06 | 653 | 249 | 18 | 22586326 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | AGO2 MYO1D MAP1B MYCBP2 MAP4 DYSF SYNJ2 CKAP4 RANBP2 DHX37 EXOSC3 GEMIN5 UPF1 EXOSC2 CYFIP2 MYOF RUVBL1 TJP1 MACF1 | 1.41e-06 | 724 | 249 | 19 | 36232890 |
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 10085069 | ||
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 38849523 | ||
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 9674433 | ||
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 1.44e-06 | 4 | 249 | 3 | 28117393 | |
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 1.44e-06 | 4 | 249 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 1.44e-06 | 4 | 249 | 3 | 29502968 | |
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 12727991 | ||
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 1.44e-06 | 4 | 249 | 3 | 7972015 | |
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 10490827 | ||
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 27941888 | ||
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 1.44e-06 | 4 | 249 | 3 | 25999467 | |
| Pubmed | 1.44e-06 | 4 | 249 | 3 | 34948093 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 1.44e-06 | 4 | 249 | 3 | 20080631 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.55e-06 | 28 | 249 | 5 | 15347688 | |
| Pubmed | 1.65e-06 | 152 | 249 | 9 | 34299191 | ||
| Pubmed | FNBP1 MAP1B MYCBP2 MAP4 RPN1 KATNAL1 DBT EFTUD2 DLAT CKAP4 MAP3K7 HSPA5 ARHGAP17 TARS2 EXOSC2 YARS1 CYFIP2 MSH6 RUVBL1 ALPK2 | 1.84e-06 | 809 | 249 | 20 | 32129710 | |
| Pubmed | MYCBP2 MAP4 VWA8 RPN1 UGGT1 POTEKP RANBP2 DSCAM GEMIN5 PDCD11 | 2.21e-06 | 202 | 249 | 10 | 24639526 | |
| Pubmed | AGO2 MAP4 VWA8 RPN1 UGGT1 ETFA CLPX DDB1 DPM1 ITIH2 DLAT PDIA5 C5 CKAP4 RBM47 ZNF574 A1CF NRAS DHX37 TRIM71 UPF1 ANKRD36B RUVBL1 TJP1 SUPT16H PDCD11 DIRAS2 | 2.25e-06 | 1371 | 249 | 27 | 36244648 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GPHN AHCYL1 URI1 MLEC UGGT1 ETFA MPDZ EVPL EYA1 DDB1 PTPN4 CYFIP1 CKAP4 HSPA5 NUP160 RANBP2 RANBP6 MSH6 DUSP21 TJP1 LRP1 PUS1 | 2.41e-06 | 974 | 249 | 22 | 28675297 |
| Pubmed | EVPL SYNPO NEB NUP54 DST SYNJ2 HRAS MAP3K7 HSPA5 RANBP2 KIF26B SYNE1 ARHGAP17 PRKAR1B MACF1 | 2.70e-06 | 486 | 249 | 15 | 20936779 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | ACADM MAP4 RPN1 DBT DPM1 EFTUD2 CKAP4 HSPA5 DHX37 EXOSC2 TJP1 SUPT16H PUS1 PDCD11 MICU2 | 2.70e-06 | 486 | 249 | 15 | 30940648 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | MAP4 RANBP2 ZBTB33 SYNM KIF26B ATG2B GEMIN5 DENND4C MYOF RUVBL1 TJP1 | 2.72e-06 | 256 | 249 | 11 | 33397691 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MAP1B MYCBP2 MAP4 UGGT1 ETFA MPDZ DDB1 EFTUD2 CYFIP1 DST DLAT MAP3K7 HSPA5 RANBP2 EXOSC3 GEMIN5 UPF1 EXOSC2 YARS1 CYFIP2 MSH6 RUVBL1 SUPT16H MACF1 | 3.17e-06 | 1149 | 249 | 24 | 35446349 |
| Pubmed | 3.29e-06 | 15 | 249 | 4 | 23515096 | ||
| Pubmed | 3.59e-06 | 5 | 249 | 3 | 22982107 | ||
| Interaction | NCAM1 interactions | 3.96e-06 | 101 | 245 | 9 | int:NCAM1 | |
| Interaction | UCN3 interactions | 7.17e-06 | 23 | 245 | 5 | int:UCN3 | |
| Interaction | HECTD1 interactions | AHCYL1 MLEC MAP1B MYCBP2 CENPE MAP4 RPN1 DBT DDB1 DPM1 EFTUD2 FBXO10 HRAS DLAT CKAP4 DHX37 EXOSC3 UPF1 EXOSC2 POLR3A MSH6 MB21D2 RUVBL1 SUPT16H PDCD11 MACF1 SSH2 CDH2 ZRANB1 | 9.86e-06 | 984 | 245 | 29 | int:HECTD1 |
| Interaction | COPS3 interactions | FNBP1 AHCYL1 MAP1B DDB1 PTGS2 EFTUD2 MAP3K7 HSPA5 KRAS BTBD2 RUVBL1 ZRANB1 EPB41L1 | 1.01e-05 | 245 | 245 | 13 | int:COPS3 |
| Interaction | AKAP1 interactions | URI1 MLEC RPN1 VPS13C UGGT1 ETFA DYSF OPTC CKAP4 RBM47 HSPA5 ATG2B UPF1 TARS2 YARS1 NDUFAF4 PRKAR1B MICU2 ZRANB1 | 1.37e-05 | 503 | 245 | 19 | int:AKAP1 |
| Interaction | PCDHGB2 interactions | 1.46e-05 | 44 | 245 | 6 | int:PCDHGB2 | |
| Interaction | C2CD4B interactions | 1.46e-05 | 44 | 245 | 6 | int:C2CD4B | |
| Interaction | TNIK interactions | MYCBP2 EFTUD2 CYFIP1 DST HRAS MAP3K7 KRAS NRAS KALRN SYNE1 CYFIP2 TJP1 SUPT16H PRKAR1B MACF1 CDH2 | 1.87e-05 | 381 | 245 | 16 | int:TNIK |
| Interaction | WDR76 interactions | EPHB4 MAP1B VWA8 DDB1 FREM2 HRAS HSPA5 KRAS HSPG2 RANBP2 NRAS YARS1 MSH6 SUPT16H LRP1 DDRGK1 | 1.99e-05 | 383 | 245 | 16 | int:WDR76 |
| Interaction | RUVBL1 interactions | FNBP1 SMG1 SETD1A AHCYL1 URI1 MAP1B EFTUD2 RTF1 FBXO10 MAP3K7 HSPA5 TANGO6 KRAS GEMIN5 UPF1 PPARG POLR3A RUVBL1 DDRGK1 ZRANB1 | 2.66e-05 | 575 | 245 | 20 | int:RUVBL1 |
| Interaction | AGR2 interactions | CCPG1 AGO2 MLEC MYCBP2 RPN1 UGGT1 ETFA GBP3 DDB1 NUP54 EFTUD2 DST TDRD10 HSPA5 KRAS NRAS SYNE1 DPP3 UPF1 CYFIP2 MSH6 MYOF RUVBL1 MACF1 RBM46 RAB15 ZRANB1 | 2.86e-05 | 934 | 245 | 27 | int:AGR2 |
| Interaction | PELO interactions | MYO1D SMYD2 NUP54 EFTUD2 RTF1 ZNF574 KRAS EXOSC2 RUVBL1 ZRANB1 | 2.86e-05 | 161 | 245 | 10 | int:PELO |
| Interaction | MPP7 interactions | 3.25e-05 | 101 | 245 | 8 | int:MPP7 | |
| Interaction | YARS2 interactions | VWA8 SPTB CLPX MOB2 EFTUD2 RBM47 KRAS UPF1 TARS2 YARS1 PUS1 DDRGK1 | 3.25e-05 | 235 | 245 | 12 | int:YARS2 |
| Interaction | RAE1 interactions | MAP1B MYCBP2 CENPE MAP4 NUP54 NUP160 KRAS RANBP2 POLR3A TJP1 DDRGK1 ZRANB1 | 3.39e-05 | 236 | 245 | 12 | int:RAE1 |
| Interaction | HEPH interactions | 3.46e-05 | 6 | 245 | 3 | int:HEPH | |
| Interaction | EXOSC4 interactions | MAP1B ETFA EFTUD2 KRAS EXOSC3 UPF1 EXOSC2 POLR3A PDCD11 DDRGK1 ZRANB1 | 3.87e-05 | 202 | 245 | 11 | int:EXOSC4 |
| Interaction | PCDHA9 interactions | 3.93e-05 | 32 | 245 | 5 | int:PCDHA9 | |
| Interaction | HM13 interactions | 4.92e-05 | 138 | 245 | 9 | int:HM13 | |
| Interaction | COL17A1 interactions | 5.32e-05 | 34 | 245 | 5 | int:COL17A1 | |
| Interaction | PCDHA8 interactions | 5.35e-05 | 55 | 245 | 6 | int:PCDHA8 | |
| Interaction | RYK interactions | EPHB4 CDHR1 F5 ITIH2 FREM2 CYFIP1 DST PCDHGA11 FAT3 PCDHB2 CDH2 | 6.00e-05 | 212 | 245 | 11 | int:RYK |
| Interaction | SLC1A3 interactions | 7.94e-05 | 85 | 245 | 7 | int:SLC1A3 | |
| Interaction | ACE2 interactions | MYO1D MAP4 RPN1 SPTB ETFA DPM1 EFTUD2 CYFIP1 HRAS DLAT CKAP4 HSPA5 NUP160 HSPG2 RANBP2 GEMIN5 UPF1 TARS2 YARS1 CYFIP2 MSH6 MYOF MB21D2 RUVBL1 SUPT16H PUS1 PDCD11 CDH2 DIRAS2 | 8.24e-05 | 1106 | 245 | 29 | int:ACE2 |
| Interaction | EXD2 interactions | VWA8 ETFA CLPX DBT DLAT NUP160 KRAS HTRA2 RANBP6 UPF1 TARS2 NDUFAF4 PUS1 DDRGK1 ZRANB1 | 8.69e-05 | 388 | 245 | 15 | int:EXD2 |
| Interaction | DECR1 interactions | 8.74e-05 | 116 | 245 | 8 | int:DECR1 | |
| Interaction | APC interactions | MYCBP2 SYNPO NEB PTGS2 NUP54 DST HRAS TRIM36 HSPA5 RANBP2 HTRA2 SYNE1 GUCY2C MACF1 ZRANB1 | 8.94e-05 | 389 | 245 | 15 | int:APC |
| Interaction | C2orf72 interactions | 9.50e-05 | 8 | 245 | 3 | int:C2orf72 | |
| Interaction | PTGES3 interactions | AHCYL1 URI1 ZGRF1 SMYD2 EFTUD2 PPIP5K2 FNIP2 RANBP2 GEMIN5 SIM2 POLR3A MSH6 RUVBL1 PDCD11 DDRGK1 ZRANB1 | 9.57e-05 | 437 | 245 | 16 | int:PTGES3 |
| Interaction | PDGFB interactions | 9.90e-05 | 88 | 245 | 7 | int:PDGFB | |
| Interaction | CEP104 interactions | 1.06e-04 | 89 | 245 | 7 | int:CEP104 | |
| Interaction | ANKRD55 interactions | RPN1 ETFA DDB1 DPM1 EFTUD2 HSPA5 NUP160 RANBP2 UPF1 RUVBL1 PDCD11 | 1.15e-04 | 228 | 245 | 11 | int:ANKRD55 |
| Interaction | TRPM4 interactions | 1.19e-04 | 40 | 245 | 5 | int:TRPM4 | |
| Interaction | ZC3H15 interactions | 1.24e-04 | 122 | 245 | 8 | int:ZC3H15 | |
| Interaction | RMND1 interactions | 1.26e-04 | 192 | 245 | 10 | int:RMND1 | |
| Interaction | KDF1 interactions | GPHN RPN1 EFTUD2 CYFIP1 HRAS CKAP4 KRAS RANBP2 TARS2 SUPT16H | 1.26e-04 | 192 | 245 | 10 | int:KDF1 |
| Interaction | SPTAN1 interactions | GPHN MYCBP2 CENPE SPTB SYNPO EFTUD2 SPTBN5 CYFIP1 DST HRAS HSPA5 KRAS NRAS KALRN CYFIP2 TJP1 ZRANB1 | 1.29e-04 | 496 | 245 | 17 | int:SPTAN1 |
| Interaction | XAGE1A interactions | 1.34e-04 | 41 | 245 | 5 | int:XAGE1A | |
| Interaction | COX4I1 interactions | MYO1D VWA8 ETFA CLPX DBT DST DLAT CKAP4 HSPA5 KRAS HTRA2 TARS2 NDUFAF4 DUSP21 MICU2 ZRANB1 | 1.41e-04 | 452 | 245 | 16 | int:COX4I1 |
| Interaction | ACSS3 interactions | 1.41e-04 | 9 | 245 | 3 | int:ACSS3 | |
| Interaction | PDZK1P1 interactions | 1.47e-04 | 2 | 245 | 2 | int:PDZK1P1 | |
| Interaction | GSK3B interactions | MAP1B MAP4 VWA8 MPDZ EYA1 SMYD2 EFTUD2 CABYR CYFIP1 DST MAP3K7 HSPA5 HTRA2 KIF26B ATG2B DPP3 DENND4C YARS1 MYOF TJP1 PRKAR1B PDCD11 MACF1 ZRANB1 | 1.60e-04 | 868 | 245 | 24 | int:GSK3B |
| Interaction | CCDC8 interactions | MYO1D MAP1B MYCBP2 MAP4 UGGT1 ETFA F5 EFTUD2 DST UCK2 CKAP4 HSPA5 KRAS RANBP2 DNAH12 RUVBL1 TJP1 PDCD11 MACF1 ZRANB1 | 1.62e-04 | 656 | 245 | 20 | int:CCDC8 |
| Interaction | MTG2 interactions | ACADM VWA8 ETFA CLPX DBT DLAT KRAS TARS2 NDUFAF4 LRP1 PUS1 ZRANB1 | 1.67e-04 | 279 | 245 | 12 | int:MTG2 |
| Interaction | PPP1R12A interactions | FNBP1 AHCYL1 MYCBP2 RPN1 SYNPO KRAS RANBP2 UPF1 RUVBL1 PUS1 MACF1 ROCK1 ZRANB1 | 1.68e-04 | 322 | 245 | 13 | int:PPP1R12A |
| Interaction | COPS5 interactions | AHCYL1 CCPG1 AGO2 MLEC RPN1 DDB1 PTGS2 EFTUD2 CYFIP1 FBXO10 DLAT CKAP4 MAP3K7 HSPA5 BRWD1 KRAS DSCAM DNAH2 GEMIN5 UPF1 BTBD2 PPARG CYFIP2 RUVBL1 LRP1 MICU2 ZRANB1 EPB41L1 | 1.86e-04 | 1102 | 245 | 28 | int:COPS5 |
| Interaction | ATG16L1 interactions | MYO1D MYCBP2 MAP4 RPN1 VPS13C INPP5D DBT DDB1 DPM1 NUP54 CYFIP1 PDIA5 CKAP4 TRIM36 NUP160 KRAS RANBP2 ATG2B RANBP6 GEMIN5 DENND4C CYFIP2 MYOF THADA MB21D2 RUVBL1 SUPT16H DDRGK1 ZRANB1 | 1.89e-04 | 1161 | 245 | 29 | int:ATG16L1 |
| Interaction | TRPV2 interactions | 2.00e-04 | 10 | 245 | 3 | int:TRPV2 | |
| Interaction | ZBTB12 interactions | 2.00e-04 | 10 | 245 | 3 | int:ZBTB12 | |
| Interaction | RUVBL2 interactions | FNBP1 SMG1 SETD1A URI1 AGO2 MAP1B MAP4 RDM1 DDB1 EFTUD2 HSPA5 TANGO6 KRAS GEMIN5 UPF1 PPARG POLR3A RUVBL1 ZRANB1 | 2.04e-04 | 616 | 245 | 19 | int:RUVBL2 |
| Interaction | NTRK3 interactions | FNBP1 AHCYL1 CCPG1 RPN1 INPP5D UGGT1 DPM1 HRAS HSPA5 DENND4C CYFIP2 MB21D2 DDRGK1 CDH2 | 2.08e-04 | 374 | 245 | 14 | int:NTRK3 |
| Interaction | MYBPC2 interactions | 2.09e-04 | 45 | 245 | 5 | int:MYBPC2 | |
| Interaction | CADM1 interactions | 2.09e-04 | 45 | 245 | 5 | int:CADM1 | |
| Interaction | WWTR1 interactions | GPHN AGO2 MAP1B MYCBP2 MPDZ CYFIP1 HSPA5 ZBTB33 ATG2B GEMIN5 PPARG MSH6 RUVBL1 TJP1 PDCD11 | 2.18e-04 | 422 | 245 | 15 | int:WWTR1 |
| Interaction | SLFN11 interactions | CCPG1 MYO1D MAP1B DBT DDB1 CKAP4 HSPA5 NUP160 RANBP2 ZBTB33 SYNM DHX37 RUVBL1 CENPI | 2.20e-04 | 376 | 245 | 14 | int:SLFN11 |
| Interaction | EIF4E2 interactions | AGO2 TGM5 EFTUD2 TMCC2 HSPA5 RALGPS2 EXOSC3 CCNQ EXOSC2 DENND4C ZRANB1 | 2.23e-04 | 246 | 245 | 11 | int:EIF4E2 |
| Interaction | RHOF interactions | EPHB4 AHCYL1 MYO1D RPN1 MPDZ DPM1 CYFIP1 UCK2 CKAP4 KIF26B RALGAPB DENND4C YARS1 MYOF TJP1 SUPT16H PUS1 MACF1 ROCK1 EPB41L1 | 2.26e-04 | 673 | 245 | 20 | int:RHOF |
| Interaction | PHLPP1 interactions | MAP4 NEB KRAS RANBP2 ZBTB33 SYNM KIF26B ATG2B GEMIN5 DENND4C MYOF RUVBL1 TJP1 | 2.33e-04 | 333 | 245 | 13 | int:PHLPP1 |
| Interaction | RHOD interactions | EPHB4 AHCYL1 RPN1 SPTB CYFIP1 HRAS CKAP4 KRAS KIF26B RALGAPB DENND4C MYOF PUS1 DDRGK1 MACF1 ROCK1 CDH2 EPB41L1 | 2.35e-04 | 572 | 245 | 18 | int:RHOD |
| Interaction | USP10 interactions | NLRP7 MYCBP2 MAP4 RPN1 EFTUD2 CKAP4 HSPA5 GEMIN5 UPF1 RUVBL1 DDRGK1 ZRANB1 | 2.39e-04 | 290 | 245 | 12 | int:USP10 |
| Interaction | NRIP1 interactions | 2.42e-04 | 170 | 245 | 9 | int:NRIP1 | |
| Interaction | ADD1 interactions | 2.53e-04 | 171 | 245 | 9 | int:ADD1 | |
| Interaction | CLDN1 interactions | 2.58e-04 | 26 | 245 | 4 | int:CLDN1 | |
| Interaction | UPF3B interactions | 2.63e-04 | 136 | 245 | 8 | int:UPF3B | |
| Interaction | ZDHHC18 interactions | 2.82e-04 | 74 | 245 | 6 | int:ZDHHC18 | |
| Interaction | RHOJ interactions | EPHB4 FNBP1 AHCYL1 MYO1D RPN1 VPS13C DPM1 CYFIP1 CKAP4 DHX37 RALGAPB YARS1 MYOF SUPT16H PUS1 MACF1 ROCK1 CDH2 EPB41L1 | 2.87e-04 | 633 | 245 | 19 | int:RHOJ |
| Interaction | CLASP1 interactions | 2.90e-04 | 138 | 245 | 8 | int:CLASP1 | |
| Interaction | KLRG2 interactions | 2.98e-04 | 105 | 245 | 7 | int:KLRG2 | |
| Interaction | TLR9 interactions | 3.03e-04 | 75 | 245 | 6 | int:TLR9 | |
| Interaction | BRD7 interactions | ACADM MAP4 RPN1 DBT DPM1 EFTUD2 CKAP4 HSPA5 DHX37 GEMIN5 BTBD2 PPARG EXOSC2 TJP1 SUPT16H PUS1 PDCD11 MICU2 ZRANB1 | 3.10e-04 | 637 | 245 | 19 | int:BRD7 |
| Interaction | RHOG interactions | EPHB4 FNBP1 AHCYL1 VWA8 RPN1 ETFA CLPX DBT CYFIP1 HRAS DLAT CKAP4 KIF26B RALGAPB TARS2 CYFIP2 MYOF NDUFAF4 TENM4 DDRGK1 MACF1 ROCK1 CDH2 EPB41L1 | 3.20e-04 | 910 | 245 | 24 | int:RHOG |
| Interaction | SFN interactions | SETD1A MAP1B MYCBP2 MAP4 NEB ITK DST SYNJ2 HSPA5 KRAS ZBTB33 KIF26B RALGPS2 DENND4C CYFIP2 TJP1 SUPT16H MACF1 SSH2 ZRANB1 | 3.24e-04 | 692 | 245 | 20 | int:SFN |
| Interaction | C9orf72 interactions | AGO2 MLEC ACADM MYCBP2 RPN1 UGGT1 ETFA CLPX DDB1 DPM1 EFTUD2 CYFIP1 HRAS UCK2 RAB39B HSPA5 NUP160 KRAS RGPD2 RANBP2 ZBTB33 NRAS HTRA2 DHX37 UPF1 TARS2 EXOSC2 POLR3A MSH6 NDUFAF4 RUVBL1 | 3.27e-04 | 1319 | 245 | 31 | int:C9orf72 |
| Interaction | USE1 interactions | 3.36e-04 | 141 | 245 | 8 | int:USE1 | |
| Interaction | RND2 interactions | EPHB4 FNBP1 RPN1 DBT DPM1 CYFIP1 DST CKAP4 KIF26B RALGAPB YARS1 MYOF SUPT16H DDRGK1 EPB41L1 | 3.39e-04 | 440 | 245 | 15 | int:RND2 |
| Interaction | CARMIL2 interactions | 3.47e-04 | 28 | 245 | 4 | int:CARMIL2 | |
| Interaction | GPS1 interactions | FNBP1 MAP1B DDB1 FBXO10 HSPA5 RANBP2 SYNE1 BTBD2 RUVBL1 ZRANB1 | 3.50e-04 | 218 | 245 | 10 | int:GPS1 |
| Interaction | CALR3 interactions | 3.52e-04 | 142 | 245 | 8 | int:CALR3 | |
| Interaction | GTSF1 interactions | 3.60e-04 | 12 | 245 | 3 | int:GTSF1 | |
| Interaction | EXOSC2 interactions | 3.69e-04 | 180 | 245 | 9 | int:EXOSC2 | |
| Interaction | SPECC1 interactions | 3.69e-04 | 143 | 245 | 8 | int:SPECC1 | |
| Interaction | EXOC1 interactions | 3.69e-04 | 143 | 245 | 8 | int:EXOC1 | |
| Interaction | SYNE3 interactions | CCPG1 AGO2 MLEC CENPE RPN1 VPS13C UGGT1 DST PDIA5 CKAP4 HSPA5 RANBP2 SYNM DDRGK1 MACF1 | 3.73e-04 | 444 | 245 | 15 | int:SYNE3 |
| Interaction | LGR4 interactions | MYCBP2 MAP4 VWA8 RPN1 UGGT1 POTEKP HSPA5 RANBP2 DSCAM GEMIN5 PDCD11 | 3.82e-04 | 262 | 245 | 11 | int:LGR4 |
| Interaction | SNAPC1 interactions | 3.96e-04 | 110 | 245 | 7 | int:SNAPC1 | |
| Interaction | HSP90B1 interactions | SMG1 ACADM MAP1B GLT1D1 RPN1 VPS13C UGGT1 POTEKP EYA1 ITGAD HCN2 EFTUD2 CKAP4 MAP3K7 HSPA5 LRRC63 KRAS LRP1 ZRANB1 | 3.98e-04 | 650 | 245 | 19 | int:HSP90B1 |
| Interaction | LRRC8D interactions | 3.99e-04 | 29 | 245 | 4 | int:LRRC8D | |
| Interaction | HHIPL1 interactions | 3.99e-04 | 29 | 245 | 4 | int:HHIPL1 | |
| Interaction | BTK interactions | 4.05e-04 | 145 | 245 | 8 | int:BTK | |
| Interaction | TMEM131 interactions | 4.05e-04 | 145 | 245 | 8 | int:TMEM131 | |
| Interaction | NCBP1 interactions | AGO2 EFTUD2 RBM47 HSPA5 ZNF574 KRAS GEMIN5 UPF1 RUVBL1 TJP1 PUS1 DDRGK1 ZRANB1 | 4.08e-04 | 353 | 245 | 13 | int:NCBP1 |
| Interaction | HSP90AB2P interactions | 4.18e-04 | 111 | 245 | 7 | int:HSP90AB2P | |
| Interaction | KCNA3 interactions | AHCYL1 MLEC MYO1D MAP1B MAP4 RPN1 MPDZ DDB1 DPM1 CYFIP1 DST CKAP4 HSPA5 RANBP2 ZBTB33 ATG2B UPF1 DENND4C MB21D2 RUVBL1 MACF1 ROCK1 EPB41L1 | 4.20e-04 | 871 | 245 | 23 | int:KCNA3 |
| Interaction | MFAP3L interactions | 4.38e-04 | 3 | 245 | 2 | int:MFAP3L | |
| Interaction | C2CD2L interactions | 4.42e-04 | 112 | 245 | 7 | int:C2CD2L | |
| Interaction | CLASP2 interactions | 4.44e-04 | 147 | 245 | 8 | int:CLASP2 | |
| Interaction | GEMIN5 interactions | MAP4 DDB1 EFTUD2 RTF1 AK1 PCGF1 GEMIN5 EXOSC2 RUVBL1 DDRGK1 ZRANB1 | 4.48e-04 | 267 | 245 | 11 | int:GEMIN5 |
| Interaction | SLC1A4 interactions | 4.56e-04 | 30 | 245 | 4 | int:SLC1A4 | |
| Interaction | GEN1 interactions | 4.56e-04 | 30 | 245 | 4 | int:GEN1 | |
| Cytoband | 5q31 | CDKL3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHB2 PCDHA7 PCDHB18P PCDHGB4 | 2.40e-07 | 115 | 249 | 8 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 1.60e-04 | 147 | 249 | 6 | chr15q15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | CDKL3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHB2 PCDHA7 PCDHB18P PCDHGB4 | 2.44e-04 | 298 | 249 | 8 | chr5q31 |
| GeneFamily | Clustered protocadherins | 3.08e-06 | 64 | 178 | 7 | 20 | |
| GeneFamily | Ferlin family | 1.84e-05 | 6 | 178 | 3 | 828 | |
| GeneFamily | EF-hand domain containing|Plakins | 5.07e-05 | 8 | 178 | 3 | 939 | |
| GeneFamily | AAA ATPases | 1.71e-04 | 53 | 178 | 5 | 413 | |
| GeneFamily | RAS type GTPase family | 2.32e-04 | 31 | 178 | 4 | 389 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 5.71e-04 | 4 | 178 | 2 | 1244 | |
| GeneFamily | Fibronectin type III domain containing | 1.05e-03 | 160 | 178 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.09e-03 | 161 | 178 | 7 | 593 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.96e-03 | 7 | 178 | 2 | 1113 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 4.62e-06 | 167 | 248 | 10 | M6699 | |
| Coexpression | WEBER_METHYLATED_HCP_IN_SPERM_DN | 7.18e-06 | 29 | 248 | 5 | M1808 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 MDGA2 ADGRV1 NEB FREM2 SYCP2 PCDH11X COL12A1 KALRN STXBP5L KIF26B FAT3 LOXHD1 TENM4 HMCN1 DGKK | 8.81e-15 | 184 | 249 | 16 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 MDGA2 ADGRV1 NEB FREM2 SYCP2 PCDH11X COL12A1 KALRN STXBP5L KIF26B FAT3 LOXHD1 TENM4 HMCN1 DGKK | 8.81e-15 | 184 | 249 | 16 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 MDGA2 ADGRV1 NEB FREM2 SYCP2 PCDH11X COL12A1 KALRN STXBP5L KIF26B FAT3 LOXHD1 TENM4 HMCN1 DGKK | 8.81e-15 | 184 | 249 | 16 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | GABRG3 IGFN1 NUP210L NEB FER1L6 ITK TMCC2 DSCAM STXBP5L PTPRT | 4.65e-08 | 171 | 249 | 10 | b2e753e811a7639956994609f73efcdb62d04f82 |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SMG1 ANKRD36C ITK RSPH10B2 ATAD2B AK1 BRWD1 PCDHGA11 SYNE1 MACF1 | 1.45e-07 | 193 | 249 | 10 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-07 | 194 | 249 | 10 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.59e-07 | 195 | 249 | 10 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-07 | 195 | 249 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.59e-07 | 195 | 249 | 10 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | GABRG3 DST CHST2 KALRN FAT3 NAALADL2 ITIH5 PLXDC2 LRP1 MACF1 | 1.67e-07 | 196 | 249 | 10 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-06 | 136 | 249 | 8 | 82d7f90ef2a63a3137c331efd68c036cd0db3ac1 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.09e-06 | 186 | 249 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 190 | 249 | 9 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-06 | 193 | 249 | 9 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-06 | 193 | 249 | 9 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-06 | 193 | 249 | 9 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 195 | 249 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 196 | 249 | 9 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 196 | 249 | 9 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 196 | 249 | 9 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 196 | 249 | 9 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 197 | 249 | 9 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.82e-06 | 198 | 249 | 9 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-06 | 199 | 249 | 9 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-06 | 199 | 249 | 9 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 249 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 249 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.10e-06 | 150 | 249 | 8 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.82e-06 | 156 | 249 | 8 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.73e-06 | 162 | 249 | 8 | 8278dccdb139396ede34b83b02ebce837f2489d6 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.90e-06 | 163 | 249 | 8 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.90e-06 | 163 | 249 | 8 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.90e-06 | 163 | 249 | 8 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 167 | 249 | 8 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Fos_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.77e-06 | 80 | 249 | 6 | b661644806e225f215047e78ae46d7cee6efde4f | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 176 | 249 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 7.16e-06 | 177 | 249 | 8 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-06 | 178 | 249 | 8 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.78e-06 | 179 | 249 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.78e-06 | 179 | 249 | 8 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.78e-06 | 179 | 249 | 8 | f378307eb20f002450c748b7be2289d6db2fcbcb | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.23e-06 | 129 | 249 | 7 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-06 | 185 | 249 | 8 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.03e-05 | 186 | 249 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 186 | 249 | 8 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-05 | 188 | 249 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Control-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.25e-05 | 191 | 249 | 8 | 3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 138 | 249 | 7 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 192 | 249 | 8 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 192 | 249 | 8 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 192 | 249 | 8 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.30e-05 | 192 | 249 | 8 | 5af3b2b38495e925497c48f605d618bbf970965d | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.30e-05 | 192 | 249 | 8 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-05 | 192 | 249 | 8 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 1.34e-05 | 139 | 249 | 7 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 193 | 249 | 8 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 193 | 249 | 8 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 193 | 249 | 8 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 193 | 249 | 8 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 194 | 249 | 8 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 194 | 249 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 194 | 249 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.40e-05 | 194 | 249 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-05 | 194 | 249 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 195 | 249 | 8 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 195 | 249 | 8 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 195 | 249 | 8 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 195 | 249 | 8 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.45e-05 | 195 | 249 | 8 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.45e-05 | 195 | 249 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Mild/Remission-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.45e-05 | 195 | 249 | 8 | 52bdd609253613b7db75dccbc1c01c05e8d73f79 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 196 | 249 | 8 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.50e-05 | 196 | 249 | 8 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 196 | 249 | 8 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 197 | 249 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.56e-05 | 197 | 249 | 8 | 3b1c574b3d119b63967bb1306f0353ecc4c522f3 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.56e-05 | 197 | 249 | 8 | 6fe013f98c64b3c5a4e61002254717fb411f8e59 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.56e-05 | 197 | 249 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-05 | 197 | 249 | 8 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-05 | 197 | 249 | 8 | 15bcfe6105c0b508811fb9bba0bc4312fea04f4c | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class | 1.56e-05 | 197 | 249 | 8 | 344801997b89bd81d8d5c3c872934de523233a8d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 198 | 249 | 8 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 198 | 249 | 8 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 198 | 249 | 8 | b027a141ab531d0f5d6a26811a53427e7b0771dd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-05 | 198 | 249 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.68e-05 | 199 | 249 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.68e-05 | 199 | 249 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-05 | 199 | 249 | 8 | dbf0bf09896c46155ae6fbd6307f097799e7e34e | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-05 | 199 | 249 | 8 | 9314eb9a89407738626a0384884454b5f9031ee7 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.68e-05 | 199 | 249 | 8 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.74e-05 | 200 | 249 | 8 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.74e-05 | 200 | 249 | 8 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.74e-05 | 200 | 249 | 8 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.74e-05 | 200 | 249 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.74e-05 | 200 | 249 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Influenza|World / Disease, condition lineage and cell class | 1.74e-05 | 200 | 249 | 8 | df996c35907a1c9194b9e2ca30e81f520ca067f0 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.74e-05 | 200 | 249 | 8 | e57452b73abb21cb3f645d45523ab93f6bef0243 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-05 | 200 | 249 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-05 | 200 | 249 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.01e-05 | 148 | 249 | 7 | fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0 | |
| Disease | Thyroid Neoplasm | 5.12e-07 | 37 | 240 | 6 | C0040136 | |
| Disease | Verrucous epidermal nevus | 5.31e-07 | 3 | 240 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 5.31e-07 | 3 | 240 | 3 | C4552097 | |
| Disease | Linear nevus sebaceous syndrome | 5.31e-07 | 3 | 240 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 5.31e-07 | 3 | 240 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 5.31e-07 | 3 | 240 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 5.31e-07 | 3 | 240 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 5.31e-07 | 3 | 240 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Linear Verrucous Epidermal Nevus | 5.31e-07 | 3 | 240 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 5.31e-07 | 3 | 240 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | Organoid Nevus Phakomatosis | 5.31e-07 | 3 | 240 | 3 | C0265329 | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 5.31e-07 | 3 | 240 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Thyroid carcinoma | 1.48e-06 | 44 | 240 | 6 | C0549473 | |
| Disease | NEVUS, EPIDERMAL (disorder) | 5.25e-06 | 5 | 240 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 5.25e-06 | 5 | 240 | 3 | C0206682 | |
| Disease | Thyroid Gland Follicular Adenoma | 9.08e-06 | 35 | 240 | 5 | C0151468 | |
| Disease | Hemimegalencephaly | 1.04e-05 | 6 | 240 | 3 | C0431391 | |
| Disease | Thyroid cancer, follicular | 1.82e-05 | 7 | 240 | 3 | C2931367 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.82e-05 | 7 | 240 | 3 | DOID:11724 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | MAP1B F5 PTGS2 BMP6 CABYR PCDH11X KRAS NRAS KALRN SYNE1 FRMPD2 RBP3 PPARG PTPRT MSH6 DUSP21 GUCY2C LRP1 | 2.01e-05 | 702 | 240 | 18 | C0009402 |
| Disease | childhood trauma measurement, alcohol consumption measurement | 2.50e-05 | 71 | 240 | 6 | EFO_0007878, EFO_0007979 | |
| Disease | RASopathy (implicated_via_orthology) | 4.31e-05 | 9 | 240 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 6.59e-05 | 2 | 240 | 2 | 614470 | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 6.59e-05 | 2 | 240 | 2 | 137550 | |
| Disease | Melanocytic nevus | 6.59e-05 | 2 | 240 | 2 | cv:C0027962 | |
| Disease | Hemopericardium | 6.59e-05 | 2 | 240 | 2 | C0019064 | |
| Disease | Large congenital melanocytic nevus | 6.59e-05 | 2 | 240 | 2 | cv:C1842036 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 6.59e-05 | 2 | 240 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 6.59e-05 | 2 | 240 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | Pericardial effusion | 6.59e-05 | 2 | 240 | 2 | C0031039 | |
| Disease | protein SEC13 homolog measurement | 6.59e-05 | 2 | 240 | 2 | EFO_0801961 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 6.59e-05 | 2 | 240 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 6.59e-05 | 2 | 240 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Chylopericardium | 6.59e-05 | 2 | 240 | 2 | C0242426 | |
| Disease | Noonan Syndrome 1 | 8.36e-05 | 11 | 240 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 8.36e-05 | 11 | 240 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 8.36e-05 | 11 | 240 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 8.36e-05 | 11 | 240 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | glycine measurement | 1.35e-04 | 137 | 240 | 7 | EFO_0009767 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 1.43e-04 | 13 | 240 | 3 | EFO_0006514, EFO_0010316 | |
| Disease | late-onset Alzheimers disease | 1.52e-04 | 292 | 240 | 10 | EFO_1001870 | |
| Disease | whole-brain volume, Alzheimer's disease biomarker measurement | 1.81e-04 | 14 | 240 | 3 | EFO_0005089, EFO_0006514 | |
| Disease | junctophilin-1 measurement | 1.97e-04 | 3 | 240 | 2 | EFO_0802667 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 1.97e-04 | 3 | 240 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 1.97e-04 | 3 | 240 | 2 | C1842036 | |
| Disease | RASopathy | 2.25e-04 | 15 | 240 | 3 | cv:C5555857 | |
| Disease | Malignant neoplasm of penis | 3.91e-04 | 4 | 240 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 3.91e-04 | 4 | 240 | 2 | C0030849 | |
| Disease | B-cell antigen receptor complex-associated protein alpha chain measurement | 3.91e-04 | 4 | 240 | 2 | EFO_0801402 | |
| Disease | BLADDER CANCER | 3.91e-04 | 4 | 240 | 2 | 109800 | |
| Disease | Epidermal nevus | 3.91e-04 | 4 | 240 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 3.91e-04 | 4 | 240 | 2 | cv:C0005684 | |
| Disease | Malignant tumor of cervix | 3.91e-04 | 4 | 240 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 3.91e-04 | 4 | 240 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | E3 ubiquitin-protein ligase DTX1 measurement | 3.91e-04 | 4 | 240 | 2 | EFO_0802503 | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 3.91e-04 | 4 | 240 | 2 | 188470 | |
| Disease | NEVUS, EPIDERMAL | 3.91e-04 | 4 | 240 | 2 | 162900 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 3.91e-04 | 4 | 240 | 2 | C4011754 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 3.91e-04 | 4 | 240 | 2 | cv:C4225426 | |
| Disease | guanylyl cyclase-activating protein 1 measurement | 3.91e-04 | 4 | 240 | 2 | EFO_0801663 | |
| Disease | diastolic blood pressure, systolic blood pressure | AHCYL1 MAP1B MOB2 RTF1 AK1 TANGO6 RALGPS2 DNAH2 PPARG MSH6 TENM4 RUVBL1 PLXDC2 LRP1 CDH2 | 4.25e-04 | 670 | 240 | 15 | EFO_0006335, EFO_0006336 |
| Disease | high grade glioma (implicated_via_orthology) | 4.49e-04 | 44 | 240 | 4 | DOID:3070 (implicated_via_orthology) | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 4.68e-04 | 19 | 240 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 4.68e-04 | 19 | 240 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 4.68e-04 | 19 | 240 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 4.68e-04 | 19 | 240 | 3 | C0587248 | |
| Disease | leukemia (implicated_via_orthology) | 4.68e-04 | 19 | 240 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | platelet component distribution width | EPHB4 RPN1 NUP210L CYFIP1 SYNJ2 ATAD2B TMCC2 PDIA5 CHST2 BRWD1 KALRN SYNE1 BTBD2 PPARG SIDT2 MACF1 | 4.99e-04 | 755 | 240 | 16 | EFO_0007984 |
| Disease | hair colour measurement | GABRG3 ADGRV1 FREM2 TMCC2 PLAT KRAS NRAS RANBP6 AREG THADA TENM4 PLXDC2 LRP1 EPB41L1 | 5.59e-04 | 615 | 240 | 14 | EFO_0007822 |
| Disease | Insulinogenic index measurement | 6.48e-04 | 5 | 240 | 2 | EFO_0009961 | |
| Disease | Cerebellar Ataxia | 6.48e-04 | 5 | 240 | 2 | C0007758 | |
| Disease | Cis-4-decenoyl carnitine measurement | 6.48e-04 | 5 | 240 | 2 | EFO_0022091 | |
| Disease | cadherin-7 measurement | 6.48e-04 | 5 | 240 | 2 | EFO_0801438 | |
| Disease | Malignant neoplasm of thyroid | 6.48e-04 | 5 | 240 | 2 | C0007115 | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 6.48e-04 | 5 | 240 | 2 | C4225426 | |
| Disease | Cetuximab response | 6.48e-04 | 5 | 240 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 6.48e-04 | 5 | 240 | 2 | C0302592 | |
| Disease | Panitumumab response | 6.48e-04 | 5 | 240 | 2 | cv:CN077999 | |
| Disease | LEOPARD Syndrome | 7.30e-04 | 22 | 240 | 3 | C0175704 | |
| Disease | serum alanine aminotransferase measurement | EYA1 ITK SEPTIN14 NUP160 BRWD1 WHRN KRAS A1CF COL12A1 NRAS DNAH2 PPARG TARS2 CYFIP2 TENM4 TET1 PCDHGB4 | 8.18e-04 | 869 | 240 | 17 | EFO_0004735 |
| Disease | cortical thickness | MYCBP2 NUP210L EYA1 ADGRV1 DYSF BMP6 TRIM36 MAP3K7 FNIP2 HSPG2 COL12A1 FAT3 RALGPS2 ITIH5 THADA PLXDC2 PCDHGB4 LRP1 MACF1 SSH2 | 8.30e-04 | 1113 | 240 | 20 | EFO_0004840 |
| Disease | Malignant neoplasm of stomach | 8.35e-04 | 300 | 240 | 9 | C0024623 | |
| Disease | Noonan Syndrome | 9.48e-04 | 24 | 240 | 3 | C0028326 | |
| Disease | cytochrome c oxidase subunit 6C measurement | 9.67e-04 | 6 | 240 | 2 | EFO_0801515 | |
| Disease | Pleocytosis | 9.67e-04 | 6 | 240 | 2 | C0151857 | |
| Disease | Autoimmune lymphoproliferative syndrome | 9.67e-04 | 6 | 240 | 2 | cv:CN301239 | |
| Disease | hydrocephalus (is_implicated_in) | 9.67e-04 | 6 | 240 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | seminoma (is_implicated_in) | 9.67e-04 | 6 | 240 | 2 | DOID:4440 (is_implicated_in) | |
| Disease | Abnormal corpus callosum morphology | 9.67e-04 | 6 | 240 | 2 | C1842581 | |
| Disease | Carcinoma in situ of uterine cervix | 9.67e-04 | 6 | 240 | 2 | C0851140 | |
| Disease | torsin-1A-interacting protein 1 measurement | 9.67e-04 | 6 | 240 | 2 | EFO_0802137 | |
| Disease | solute carrier family 22 member 16 measurement | 9.67e-04 | 6 | 240 | 2 | EFO_0802079 | |
| Disease | Leukocytosis | 9.67e-04 | 6 | 240 | 2 | C0023518 | |
| Disease | Metastatic melanoma | 9.81e-04 | 54 | 240 | 4 | C0278883 | |
| Disease | mental development measurement | 1.07e-03 | 25 | 240 | 3 | EFO_0008230 | |
| Disease | paracentral lobule volume measurement | 1.07e-03 | 25 | 240 | 3 | EFO_0010317 | |
| Disease | glucose measurement | MYCBP2 VWA8 VPS13C ETFA MYL7 PDIA5 NUP160 A1CF THADA SLC25A47 | 1.18e-03 | 380 | 240 | 10 | EFO_0004468 |
| Disease | hearing impairment | 1.25e-03 | 98 | 240 | 5 | C1384666 | |
| Disease | T-cell immunoglobulin and mucin domain 1 measurement | 1.35e-03 | 7 | 240 | 2 | EFO_0010812 | |
| Disease | remission | 1.35e-03 | 7 | 240 | 2 | EFO_0009785 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VEVESIAETYGRIEK | 476 | Q9NWW7 | |
| VVALDKVPEDVQEYS | 46 | A8MTB9 | |
| YEDTLPGSEVLKVVA | 256 | Q96JP9 | |
| GTPEYKVLEDKIIQE | 341 | Q9HB65 | |
| YIVDDSVRVEQVVKP | 96 | P15514 | |
| PVIQGETRYFVKEFE | 51 | Q8TDH9 | |
| VTYPEVLKEFAQTGI | 311 | Q8N8R5 | |
| IPIEEVFKIYGADSS | 101 | Q0P641 | |
| GYVGEDIESVIAKLL | 326 | O76031 | |
| VLYGDVEELKRSVGE | 481 | Q07065 | |
| EGVVDVIVYPSAADK | 161 | Q9NQ94 | |
| IDEISVIEYTRAGKP | 1406 | Q86TB3 | |
| VEKSYELPDGQVITI | 236 | Q9BYX7 | |
| TGQIVAIKIFYERPE | 26 | Q8IVW4 | |
| YEEQGEIILKVPVEI | 141 | Q9UK96 | |
| VLKTDDDVYVNVPEL | 171 | O96024 | |
| LVVKDGATYKVDVVP | 4821 | Q8WXG9 | |
| VYNDVPVTEGVVYIE | 296 | O75952 | |
| TEEQYRIEADVTKPI | 901 | Q8N2N9 | |
| AREEIIPVAAEYDKT | 56 | P11310 | |
| QVYGVEVPAEVEAEK | 201 | Q8N1B3 | |
| IFLDTIVPKYEVNGV | 281 | P13497 | |
| VIDDRGKFIYITPEE | 261 | Q96HY6 | |
| EVPISFVDRVYGESK | 226 | O60762 | |
| PVDLREGVAKAYSVV | 1986 | Q96BY7 | |
| TPVYAEVKRVGDTVL | 526 | Q9UKV8 | |
| IEDSYRKQVVIDGET | 36 | P01112 | |
| IEDSYRKQVVIDGET | 36 | P01116 | |
| IEDSYRKQVVIDGET | 36 | P01111 | |
| VDEYAPEGVQKILIG | 106 | P59190 | |
| VTGEEDEKVLYSQRV | 2026 | P49792 | |
| IYELVKRGEITIQEG | 171 | Q96DA2 | |
| EGVVDVIVYPSATDK | 166 | Q8TBY0 | |
| IAKVTEGVLDVIVYA | 171 | A0AV96 | |
| SEYLKIPGDQVVSVV | 121 | P98160 | |
| EKGFVEPELYEEVTI | 811 | P25092 | |
| VEDTLKIYGVEVEII | 111 | Q9Y5H2 | |
| VRPNAVYDVVEEKLE | 601 | P29074 | |
| GTISAYKIVPDEIEE | 51 | Q9NQX3 | |
| GLVVPVDKNDVGYRE | 226 | Q9NWY4 | |
| EPGYLVTKVVAVDAD | 581 | Q9UN71 | |
| AAEPGYLVTKVVAVD | 581 | Q9Y5E7 | |
| AAEPGYLVTKVVAVD | 526 | Q96TA0 | |
| LVTDEDVFPTKYGRE | 121 | Q70IA6 | |
| VLESGKIAVEYRPSE | 221 | Q8NG50 | |
| KIAVEYRPSEDIVGV | 226 | Q8NG50 | |
| TEEQYRIEADVTKPI | 1326 | Q5JPF3 | |
| DDIAYVGKPLVDIET | 126 | P11182 | |
| ALKDAGVQPEEISYI | 331 | Q9NWU1 | |
| IAGPETELVDVNVYL | 686 | Q9UN72 | |
| DYEVDITVLKEPADV | 826 | P0C881 | |
| DYEVDITVLKEPADV | 826 | B2RC85 | |
| EIYEKTVEVLEPEVT | 106 | Q7L576 | |
| IAIVSEDFVPYKGDL | 136 | Q8WUE5 | |
| YEAPAIDDGKLEVVA | 956 | Q5KSL6 | |
| IKIRPGEYEQFESTI | 336 | Q9H4G0 | |
| DVERYVGGDKVIDVI | 181 | Q6ZMT4 | |
| EIIQVPGYTQEEKIE | 506 | Q86WA8 | |
| GVSVDKEGYIIVADR | 611 | Q2Q1W2 | |
| EPVEAYVIQKEREVT | 871 | P46821 | |
| EPQELVTKDLVREGY | 241 | A8MXT2 | |
| TVGKTDYIPLLDVDE | 41 | P27816 | |
| KITEEEVISGFYLVP | 261 | Q8IYB1 | |
| DVSYVKIEEVIGAGE | 611 | P54760 | |
| LIGDKVYQGEITERE | 101 | Q86UX2 | |
| ETAVDGELVVLYDVK | 266 | P19823 | |
| NIGEDTYDIVIPVKD | 436 | Q86T24 | |
| ATEPVIAFYEKRGIV | 156 | P00568 | |
| YEVPIKEEGDYVLVL | 111 | Q14165 | |
| EVDVPGKDVTELSQY | 4291 | Q03001 | |
| IEVVDYEGKGRQTII | 391 | Q07954 | |
| DPIVKVELVGRGYVE | 51 | A6NEK1 | |
| PVDIEEVSDYLEVIK | 986 | Q9ULI0 | |
| RGLGEPFEIKVYEID | 1981 | Q2KJY2 | |
| IPQSKYSVEEDVGEL | 1886 | Q5SZK8 | |
| GRLEVELYPSEVVEI | 796 | Q8IVV2 | |
| YENIPVDKVEIEIAT | 46 | Q99645 | |
| YSQLGKVSVPEEELD | 61 | Q01449 | |
| EELTDYGDQLPEVKV | 66 | Q9UBM4 | |
| VQEEGYLAKILVPEG | 266 | P10515 | |
| KIDLTVEELPAVYTG | 281 | P53370 | |
| AEPGYLVTKVVAVDR | 586 | Q9Y5H3 | |
| AAEPGYLVTKVVAVD | 581 | Q9Y5G2 | |
| GVNVLDEPYEKVVDR | 311 | A8MUH7 | |
| DEPYEKVVDRIQSSG | 316 | A8MUH7 | |
| EKEVVEFYRDPQLEG | 956 | Q92817 | |
| GRKVVYVVIGDGVEE | 546 | Q99502 | |
| ETQELLKEYGEFRVP | 1166 | O60229 | |
| IDYKEIEVEEVVGRG | 31 | O43318 | |
| ISYVEKARTVGIEEL | 531 | Q6ZR08 | |
| ELRIQGVPKVTYTEF | 261 | Q86W50 | |
| ILIGETIKIVIEDYV | 321 | P35354 | |
| VTRGDYAPILQKVVE | 246 | Q9NY33 | |
| VIFSPLEEEVKAGIY | 411 | Q9H0R5 | |
| AITEGYIAVELPKFE | 536 | Q05C16 | |
| VFLENVRYSIPEEKG | 406 | Q86XE3 | |
| VRYSIPEEKGITFDE | 411 | Q86XE3 | |
| GDKDIPVAIFYTLVI | 266 | A6NET4 | |
| YEPGEVVKQADVVLL | 491 | Q32M88 | |
| ELASAVKEQYPGIEI | 41 | Q9BRT3 | |
| VKEQYPGIEIESRLG | 46 | Q9BRT3 | |
| VYKTGDVPLIRIEED | 66 | Q9BZA7 | |
| EIYEKTVEVLEPEVT | 106 | Q96F07 | |
| KGYKVARVEQTETPE | 476 | P52701 | |
| ALKTRYIGEVGDIVV | 71 | Q13868 | |
| IIIDYGEQRTLDPEK | 721 | O00222 | |
| EVPGSVTEYKVLALD | 351 | P34949 | |
| EVLLQGSDKGVEIYE | 176 | Q7Z553 | |
| VEIYEPFFTQGETKI | 186 | Q7Z553 | |
| YLEVIPFSDIKDGVS | 2651 | Q9UPN3 | |
| VYVTPTIRGNKDEAE | 3336 | Q96RW7 | |
| EVYGDIKVTLIETEP | 1006 | O14522 | |
| LEYSDVIPQAEKAGI | 266 | Q13349 | |
| KTLPDDQTEVVIYVV | 231 | Q7Z3B4 | |
| IPKAEAYESVVRIEG | 251 | C9JE40 | |
| QERDIVPVDASYEVK | 221 | O43252 | |
| VIKVPDNYGDEIAIE | 391 | Q92900 | |
| EYDGIETLRVPADKI | 101 | Q15825 | |
| YEVTIPEKLSFRGEV | 41 | Q9UKF2 | |
| EEQKIPEDSIYIGTA | 86 | Q9ULG6 | |
| ADVVEKTAPAVVYIE | 151 | O43464 | |
| REEEITPVVSIAYKV | 21 | Q6UX52 | |
| IEVICYIEKPGVETL | 401 | Q01344 | |
| DIGEEKTRVGVVQYS | 171 | Q99715 | |
| IYEQEPLEIGKSLEI | 76 | Q9P109 | |
| IGIKPTVIDVDIYVN | 66 | Q99928 | |
| PALEKEIVVNGREYV | 306 | Q96MS3 | |
| VVEGETLYVIEEDKG | 571 | Q96RU3 | |
| YEQICEIKGDVESIP | 101 | Q96HU8 | |
| PEISAGEIYFVELVK | 941 | Q68DX3 | |
| GEIYFVELVKEDGTL | 946 | Q68DX3 | |
| ALEKGEVEESEYVVI | 556 | Q9P278 | |
| YEGKDGTIEDIITVL | 986 | Q8IVF7 | |
| PDKVRVGVVQYSDDT | 476 | A8TX70 | |
| FSEEAEIPGIKYVLS | 336 | P01031 | |
| YSVKVLEDLPVGTVI | 941 | Q8TDW7 | |
| DTGVLKVVSPLDYEV | 2236 | Q8TDW7 | |
| PEGEVVTAAEFRIYK | 246 | P22004 | |
| YGIAKVVQREDVETG | 1186 | Q5VZ89 | |
| GEYDRAVKEGPEQVI | 86 | P08861 | |
| EKLGNVESVYVIDPE | 91 | P05108 | |
| DQELVKIVGIRYEVG | 1001 | Q9NSI6 | |
| DKVAVSTEEVQYLIP | 146 | Q9BV29 | |
| KIVVQGEPGDDFYII | 281 | P31321 | |
| RPEDSGIYQVKVEDA | 281 | Q86VF2 | |
| KTVEVPYKGDVENTI | 291 | P36959 | |
| IYIDPEILEKTGVAE | 661 | Q92674 | |
| DNQPTVTIKVYEGER | 456 | P11021 | |
| YGEVVPALKEVSIAD | 186 | Q8WVV5 | |
| KFLYSDEVQIGPETV | 176 | Q9BX70 | |
| LPEFVVYQEIVETTK | 976 | Q8IY37 | |
| LPVIDYGKLRETVEQ | 2036 | Q9P225 | |
| KEYSIEEIEAGRIPN | 1726 | O75923 | |
| EIIQEVGKLYPLEIV | 216 | Q9NQT5 | |
| VDYIFLIVEKGIDSE | 301 | Q9UL51 | |
| TFYGEVPENRVDIIV | 386 | P19022 | |
| GYIREIEATGLQTKE | 1221 | Q02224 | |
| IYVVTAEGLRPVKEV | 41 | Q16531 | |
| VFFEGIQYIKVPVTD | 61 | Q9H596 | |
| ENIKEEYSVRGFPTI | 216 | Q14554 | |
| DIPGVVKTYREVVVN | 1541 | Q5VU65 | |
| DIVYKLVPGLQDSEE | 106 | Q9BSM1 | |
| VVFDVLKVTPEEYAG | 41 | Q86X27 | |
| EVVEDISTGFRLYKP | 566 | Q08881 | |
| DYVQVVLEDGTPKII | 396 | O60469 | |
| PLVVVELYDSDAVGK | 896 | Q2WGJ9 | |
| SKPVYRVAEITGVVE | 396 | Q92541 | |
| VVVIPVGSEQEEYAK | 616 | Q9BW92 | |
| PDIQLEDIAEKIEGY | 401 | Q9BW62 | |
| ENTFVVKVEGPSEYI | 341 | Q9NRF2 | |
| GIDVPEINEEQSKVY | 416 | Q9NQ86 | |
| SLYVEKIDVGEAEPR | 386 | P54577 | |
| DGLLTVEQVKEIGDY | 1081 | Q6YHU6 | |
| YEFPEGVDSVIVKVT | 176 | Q8NBJ9 | |
| VDVVNGEYVPRKSIL | 396 | O94763 | |
| KLTVVETVGYGDQID | 106 | Q6ZU15 | |
| ELVEKLYPEAEEIGA | 76 | Q8WXA3 | |
| VYLLAEEAEGIGDKV | 236 | O75069 | |
| ETKEYLGNPTIEIDA | 5341 | Q8NF91 | |
| AKVVNVEIVEEPVSY | 741 | O15061 | |
| VEIVEEPVSYVSGEK | 746 | O15061 | |
| IKLLLVGDVYGEEVA | 481 | O15056 | |
| TVGIDIVPAVESVYK | 186 | Q1RMZ1 | |
| VIVGLSKDGTDYIEI | 1511 | P12259 | |
| ELVTGEEGEKVLYSQ | 1041 | P0DJD1 | |
| EKEIVDPLYGIAEVE | 116 | Q68EM7 | |
| KALGAIVYITEIDPI | 331 | O43865 | |
| VVAIVKGYAPESVLE | 301 | Q9Y606 | |
| VASEEEEVPLVVYLK | 261 | Q8N3V7 | |
| VYVGNLPLDISKEEI | 36 | Q5VZ19 | |
| IDIDAYEEVKEIPGI | 521 | P58743 | |
| GQLVKLDPVYREEEE | 766 | A6NCM1 | |
| ADYGIVADLFKVVPE | 311 | P13804 | |
| VQEITEYAKSIPGFV | 321 | P37231 | |
| ITEEEKERIYGILGQ | 1661 | Q96Q15 | |
| NETGYQEAIVKEPEI | 216 | Q8IYU8 | |
| YVDKENEEPGILVAT | 6 | Q9NZH4 | |
| YAEVEPVGEKEGFIV | 511 | Q6UX71 | |
| EKTLLGEISEYIEEV | 1106 | O14802 | |
| LDPGAKISVIVETVY | 121 | P04843 | |
| EVTGYEPQDLIEKTL | 251 | Q14190 | |
| IYVIGTQEDPLSEKE | 446 | Q92835 | |
| KYEEASIPFVGILVE | 171 | Q9BZQ2 | |
| VGYPLDTVKVRIQTE | 16 | Q6Q0C1 | |
| YESQEEELAKVVVAP | 576 | Q8WX94 | |
| EIYPVSATGKAVVEE | 1476 | O75592 | |
| REQISLYPEVKGEIA | 41 | Q9P032 | |
| IYVSLVEPGSLAEKE | 166 | Q9P202 | |
| AVVAYTIAVKEDGEL | 166 | Q9Y5B9 | |
| VDLVSEYVDAVLGKG | 1351 | Q12769 | |
| ESLVEIADTVPKYLG | 246 | O60518 | |
| IVIYSKQPIGVDEEI | 1666 | O15047 | |
| QSVVVKVEEPGYAES | 1056 | Q9NRC6 | |
| EFQEPYAVVVLLEKD | 371 | Q9Y2K9 | |
| GNAIRIEIVVYTGKE | 1461 | Q8NFU7 | |
| RVEYVPLVEEALKIG | 231 | Q9H6R3 | |
| LKSIIEEGEYTPQVS | 171 | B2RD01 | |
| LVVRYEDLVGDPVKT | 421 | Q9Y4C5 | |
| GTEVVPAYEEENKAV | 326 | Q14028 | |
| CKAGVPEILIEEVYT | 136 | Q8NEY3 | |
| DPERVFYTGQVVKVV | 581 | Q14690 | |
| EVPQTVGKYVTELDL | 56 | Q9NR97 | |
| YRVVPGEEEQKFEVE | 376 | P00750 | |
| VLGERYGADKDVVVL | 216 | P10745 | |
| AVDDEIVVGYPIEKF | 1531 | O75970 | |
| EGVLKDLRTVIPYQE | 981 | Q76I76 | |
| VEEIQRIAEGPYIDV | 416 | Q9Y5W7 | |
| RIAEGPYIDVVKLQT | 421 | Q9Y5W7 | |
| VTVPEEKVQIYSIEV | 331 | Q9BX26 | |
| IEIYPLAEAEGVQIS | 881 | Q6ZN55 | |
| LVAIGYKDGIVVIID | 166 | Q8TEQ6 | |
| DVFKVYVVGNEPLTV | 456 | Q9C0B7 | |
| YGSRVKDIVPQEAEE | 56 | Q6N022 | |
| PVEVIYDAKTVNAVV | 631 | Q709C8 | |
| GEQELYVISDEIPKD | 1601 | P11277 | |
| YVISDEIPKDEEGAI | 1606 | P11277 | |
| ITEGKTVQIPVYDFV | 101 | Q9BZX2 | |
| EELIEAGVVQSPRYK | 16 | A0A5A6 | |
| IKEGEVDLNYDTPFV | 381 | O43548 | |
| KGIDVVVPYFISALE | 576 | Q86X10 | |
| ETKEVYEGEVTELTP | 126 | Q9Y265 | |
| QGDVYRAETEEIPKI | 1181 | Q13464 | |
| GAIPEGVEQEIYFKV | 1661 | Q07157 | |
| VIYKEIPLGEQDEEN | 46 | Q9UC06 | |
| YLITVEEVKVAGAIG | 66 | Q86YA3 | |
| TYELGSENVKVPIFE | 121 | Q6P9G4 | |
| VERDSEGKEVRYPVI | 271 | O43314 | |
| ADIVIPQEYGITKAE | 756 | O43314 | |
| PVKVLGENYTLEDEE | 506 | Q15029 | |
| AVQEIKPGEEVFTSY | 226 | Q9NRG4 | |
| SVKDGLIVYEDSPLV | 821 | A3KMH1 | |
| IIYEEALKATELVPG | 2786 | Q6ZQQ6 | |
| VIPQEYGISREEKLE | 771 | Q6PFW1 | |
| VGVVEGDLAAIEAYK | 271 | Q9UGI0 | |
| KEGETYFDVVAVVDP | 981 | Q9NYU2 | |
| GKTEVTPAAQVDVLY | 186 | Q9H400 | |
| VIGFKPEEIQTVYKI | 256 | O94832 | |
| VPIVQFAYEDIKTLE | 586 | Q58DX5 | |
| IFDEVEIYGEPQTVL | 1191 | Q9NZM1 | |
| LLGGRYSEVDKVVEV | 601 | Q5VVJ2 | |
| EEVVYEEVPGETITK | 16 | P20929 |